DeSanctis-Cacchione Syndrome – Causes and Treatment
DeSanctis-Cacchione Syndrome is an extremely rare genetic disorder combining severe UV light sensitivity, progressive neurological deterioration, and developmental delays.
Wissenswertes über "DeSanctis-Cacchione Syndrome"
DeSanctis-Cacchione Syndrome is an extremely rare genetic disorder combining severe UV light sensitivity, progressive neurological deterioration, and developmental delays.
What is DeSanctis-Cacchione Syndrome?
DeSanctis-Cacchione Syndrome is an extremely rare, autosomal recessive genetic disorder. It represents one of the most severe forms of Xeroderma Pigmentosum (XP), a condition in which the cellular ability to repair UV-induced DNA damage is severely impaired or completely absent. In addition to the classic skin manifestations of Xeroderma Pigmentosum, DeSanctis-Cacchione Syndrome is characterised by significant neurological deterioration and developmental abnormalities. The syndrome was first described in 1932 by Italian physicians Carlo De Sanctis and Aldo Cacchione.
Causes and Genetics
The underlying cause of DeSanctis-Cacchione Syndrome is a mutation in genes involved in Nucleotide Excision Repair (NER), a cellular mechanism responsible for correcting UV-induced DNA damage. The genes most commonly affected belong to the XP complementation groups, particularly XPA and XPD (ERCC2). When these repair mechanisms fail, DNA damage accumulates in skin and nerve cells, leading to the characteristic features of the syndrome.
- Inheritance pattern: autosomal recessive (both parents must carry one defective gene copy)
- Most frequently affected genes: XPA and XPD
- Estimated prevalence: fewer than 1 in 1,000,000 individuals
Symptoms
DeSanctis-Cacchione Syndrome presents with a distinctive combination of skin, neurological, and developmental symptoms:
Skin Symptoms
- Extreme photosensitivity: even minimal UV exposure causes severe sunburn
- Numerous freckles and pigmented lesions appearing in early childhood
- Dry, parchment-like skin (Xeroderma)
- Very high risk of skin cancer (basal cell carcinoma, squamous cell carcinoma, melanoma) even in childhood
Neurological Symptoms
- Progressive neurological degeneration: ongoing loss of nerve cells
- Microcephaly: abnormally small head circumference
- Ataxia: impaired coordination and balance
- Hyporeflexia or areflexia: diminished or absent reflexes
- Sensorineural hearing loss
- Spasticity and muscle weakness
Developmental Abnormalities
- Intellectual disability of varying degrees
- Growth retardation and short stature
- Hypogonadism: reduced function of the gonads
- Delayed onset of puberty
Diagnosis
The diagnosis of DeSanctis-Cacchione Syndrome is based on a combination of clinical and laboratory investigations:
- Clinical examination: identification of characteristic skin and neurological findings
- Molecular genetic testing: detection of mutations in NER genes (e.g., XPA, XPD)
- DNA repair assays using cultured skin fibroblasts: confirmation of impaired UV-induced DNA repair
- Neurological imaging (brain MRI): often reveals cerebral atrophy, demyelination, and cerebellar changes
- Neurophysiological studies: electromyography (EMG), nerve conduction velocity testing
- Audiological assessment to evaluate hearing loss
Treatment
There is currently no curative therapy for DeSanctis-Cacchione Syndrome. Management is symptomatic and focused on improving quality of life and preventing complications.
UV Protection
- Strict and consistent protection from UV radiation is the most critical intervention: protective clothing, UV-blocking eyewear, high-factor sunscreen (SPF 50+)
- Avoidance of direct sunlight, especially during peak hours
- UV-protective film on windows in homes and schools
Skin Surveillance and Cancer Management
- Regular dermatological check-ups for early detection of skin cancers
- Surgical removal of skin tumours as required
Neurological and Supportive Therapy
- Physiotherapy and occupational therapy to maintain motor function
- Speech and language therapy for communication and swallowing difficulties
- Early intervention programmes and special educational support for intellectual disability
- Pharmacological management of spasticity and seizures
Multidisciplinary Care
Given the involvement of multiple organ systems, close collaboration among dermatologists, neurologists, paediatricians, geneticists, and therapists is essential for comprehensive care.
Prognosis
The prognosis for DeSanctis-Cacchione Syndrome is serious. Neurological deterioration typically progresses over time, and many affected individuals have a reduced life expectancy. Consistent UV protection and regular medical monitoring can reduce complications such as skin cancer and improve overall quality of life. Early diagnosis and interdisciplinary management are critical to optimising outcomes.
References
- Kraemer, K. H. et al. (2007): Xeroderma pigmentosum. In: Nature Reviews Disease Primers. PMID: 17657700.
- Lehmann, A. R. et al. (2011): Xeroderma pigmentosum. In: Orphanet Journal of Rare Diseases, 6:70. DOI: 10.1186/1750-1172-6-70.
- OMIM (Online Mendelian Inheritance in Man): DeSanctis-Cacchione Syndrome, Entry #278800. Johns Hopkins University. Available at: https://www.omim.org/entry/278800
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categorylowering homocysteine
Os triquetrum
Supportive
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: DeSanctis-Cacchione Syndrome + De Sanctis-Cacchione Syndrome + DeSanctis Cacchione Syndrome